PIMURUTAMAB
UNII 5V1Y8T4RB6

Substance Identification & Data

This profile provides standardized clinical and technical data for Pimurutamab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 5V1Y8T4RB6.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2251771-76-1 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

5V1Y8T4RB6

CAS Registry Number

2251771-76-1

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

PIMURUTAMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C163981

National Cancer Institute reference terminology for clinical and research data.

INN ID

11309

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Pimurutamab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

PIMURUTAMAB

Common Names & Synonyms

PIMURUTAMAB [INN]

PIMURUTAMAB [WHO-DD]

RECOMBINANT ANTI-EGFR HUMANISED MONOCLONAL ANTIBODY-SHANGHAI HENLIUS BIOTECH

Systematic Nomenclature

IMMUNOGLOBULIN G1, ANTI-(HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR) (HUMAN MONOCLONAL HLX07 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL HLX07 .KAPPA.-CHAIN, DIMER

SYS